Consun Pharmaceutical Group Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 886.526 million compared to CNY 765.856 million a year ago. Operating income was CNY 312.932 million compared to CNY 257.410 million a year ago. Net income was CNY 250.644 million compared to CNY 208.886 million a year ago. Basic earnings per share from continuing operations was CNY 0.3132 compared to CNY 0.2527 a year ago. Diluted earnings per share from continuing operations was CNY 0.3117 compared to CNY 0.2527 a year ago.